Literature DB >> 67196

Geography in multiple sclerosis.

J F Kurtzke.   

Abstract

Both mortality and morbidity data indicate quite clearly that multiple sclerosis is a geographically-related disease, and thus MS can be thought of as an acquired environmental (exogenous) illness. High frequency parts of the world for MS are Europe between 65 degrees and 45 degrees north latitude, northern United States and southern Canada, New Zealand, and southern Australia. These regions are bounded by medium frequency MS regions: in Europe to the north, east, and south; in America for southern U.S.; and the remainder of Australia. Latin America, Asia and Africa are essentially of low frequency from present data. Latitude is not a sufficient criterion: at 40 degrees north latitude, MS is high in America, medium in Europe, and low in Asia. All high and medium risk areas therefore are in Europe or European colonies; thus MS is the white man's burden spread from western Europe. Within the U.S., MS is less common among Negroes, Japanese, and possibly Amerindians than in whites regardless of geography. Migration studies among risk areas indicate that migrants keep much of the risk of their birthplace, but also that overall the risk is decreased by high-to-low migration, and probably increased by low-to-high. For the former, it seems that adolescence is the age critical for retention of birthplace risk. Some preliminary data on a possible epidemic of MS are also presented. All the epidemiologic information would be most easily explained if MS were an infectious (viral) illness with prolonged latency. The proof of this though must come from the laboratory.

Entities:  

Mesh:

Year:  1977        PMID: 67196     DOI: 10.1007/BF00312546

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Familial and conjugal multiple sclerosis.

Authors:  K SCHAPIRA; D C POSKANZER; H MILLER
Journal:  Brain       Date:  1963-06       Impact factor: 13.501

2.  Mortality in 33 countries from diseases of the nervous system.

Authors:  I D GOLDBERG; L T KURLAND
Journal:  World Neurol       Date:  1962-06

3.  A reassessment of the distribution of multiple sclerosis.

Authors:  J F Kurtzke
Journal:  Acta Neurol Scand       Date:  1975-02       Impact factor: 3.209

4.  Further considerations on the geographic distribution of multiple sclerosis.

Authors:  J F Kurtzke
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

5.  Mortality and migration in multiple sclerosis.

Authors:  J F Kurtzke; L T Kurland; I D Goldberg
Journal:  Neurology       Date:  1971-12       Impact factor: 9.910

6.  Some epidemiologic features compatible with an infectious origin for multiple sclerosis.

Authors:  J F Kurtzke
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

7.  A Fennoscandian focus of multiple sclerosis.

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

8.  A method for estimating the age at immigration of white immigrants to South Africa, with an example of its importance.

Authors:  J F Kurtzke; G Dean; D P Botha
Journal:  S Afr Med J       Date:  1970-06-06

9.  An evaluation of the geographic distribution of multiple sclerosis.

Authors:  J F Kurtzke
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

10.  Multiple sclerosis among immigrants in Greater London.

Authors:  G Dean; H McLoughlin; R Brady; A M Adelstein; J Tallett-Williams
Journal:  Br Med J       Date:  1976-04-10
View more
  24 in total

1.  Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Authors:  M-L Sumelahti; P J Tienari; M Hakama; J Wikström
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

Review 2.  Genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

3.  Histocompatibility antigens (HLA) in multiple sclerosis in Iran.

Authors:  J Lotfi; B Nikbin; I Derakhshan; Z Aghai; F Ala
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-08       Impact factor: 10.154

4.  Comparative epidemiology of multiple sclerosis and dental caries.

Authors:  W Craelius
Journal:  J Epidemiol Community Health (1978)       Date:  1978-09

Review 5.  The noncalciotropic actions of vitamin D: recent clinical developments.

Authors:  Naim M Maalouf
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

6.  Serum vitamin d levels in Indian patients with multiple sclerosis.

Authors:  Radhakrishnan Suresh Kumar; Sajid Syed; Anandakuttan Anand Kumar; K N Subha Kumari; K Sajitha
Journal:  Indian J Clin Biochem       Date:  2012-10-11

Review 7.  Multiple sclerosis.

Authors:  C M Poser
Journal:  Med Clin North Am       Date:  1979-07       Impact factor: 5.456

8.  Vitamin D therapy in experimental allergic encephalomyelitis could be limited by opposing effects of sphingosine 1-phosphate and gelsolin dysregulation.

Authors:  Yanyan Zhu; Zhaoyu Qin; Jifang Gao; Mingchong Yang; Yanjiang Qin; Ting Shen; Shilian Liu
Journal:  Mol Neurobiol       Date:  2014-04-11       Impact factor: 5.590

Review 9.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

10.  Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis.

Authors:  Sarah-Michelle Orton; Andrew P Morris; Blanca M Herrera; Sreeram V Ramagopalan; Matthew R Lincoln; Michael J Chao; Reinhold Vieth; A Dessa Sadovnick; George C Ebers
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.